Acid Inhibitory Effect of a Combination of Omeprazole and Sodium Bicarbonate (CDFR0209) Compared With Delayed‐Release Omeprazole 40 mg Alone in Healthy Adult Male Subjects

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|7|1|53-58

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.7, Iss.1, 2018-01, pp. : 53-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generic omeprazole delayed-release capsules: in vitro performance evaluations

By Moore Terry   Smith Anjanette   Ye Wei   Toler Duckhee   Westenberger Benjamin   Lionberger Robert   Raw Andre   Yu Lawrence   Buhse Lucinda  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 8, 2009-08 ,pp. : 917-921

Informa Healthcare

Access to resources Recommend Favorite

Omeprazole/Antacid-Powder Suspension – Santarus: Omeprazole/Sodium Bicarbonate Powder – Santarus, SAN 05

By Adis International Limited  

Drugs in R&D, Vol. 5, Iss. 6, 2004-01 ,pp. : 349-350

Adis International

Access to resources Recommend Favorite

Finasteride 1 mg has no inhibitory effect on omeprazole metabolism in extensive and poor metabolizers for CYP2C19 in Japanese

By Yasumori T.   Narita H.   Matsuda T.   Takubo T.   Ogawa M.   Ishii M.   Hara K.   Ishii Y.   Okuyama K.   Fujimoto G.   Ochiai H.   Kano A.   Hasegawa S.   Sato K.   Taniguchi T.  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 11, 2006-11 ,pp. : 939-946

Springer Publishing Company

Access to resources Recommend Favorite

Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms

By Röhss Kerstin   Lind Tore   Wilder-Smith Clive  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 531-539

Springer Publishing Company

Access to resources Recommend Favorite

Review of immediate-release omeprazole for the treatment of gastric acid-related disorders

By Castell Donald  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2501-2510

Informa Healthcare

Access to resources Recommend Favorite